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Abstract 
Carbachol-stimulated accumulation of labeled IP 4 or of total Ins 1,3,4,5-P 4 in rat brain cortical slices was maximal in buffer containing 
10 mM K ÷. Iso-osmotic elevation of extracellular K + to 30 mM did not affect total Ins 1,3,4,5-P 4 accumulation but did enhance 
carbachol stimulated Ins 1,4,5@ 3 accumulation. Iso-osmotically elevated K + suppressed carbachol stimulated accumulation of labeled IP 4 
while enhancing accumulation of labeled inositol mono-, bis- and trisphosphates. High K ÷ alone increased basal accumulation of labeled 
inositol mono-, bis- and trisphosphates, and total Ins 1,4,5-P3, while having no significant effect on accumulation of labeled IP 4 or total 
Ins 1,3,4,5-P 4.Long-term incubation with hyper-osmotically e evated K ÷ potentiated carbachol-stimulated Ins 1,3,4,5-P 4 accumulation at
5 min. However, hyper-osmotically elevated K + suppressed accumulation of labeled IP 4 due to carbachol. These results indicate that 
there is no short-term effect of iso-osmotically elevated K+on carbachol-stimulated otal Ins 1,3,4,5-P 4 accumulation. Furthermore, 
elevating K+above 10 mM either iso-osmotically or hyper-osmotically suppresses carbachol stimulated accumulation of labeled IP 4. The 
results uggest that the altered Na+/K ÷ ratio influenced the production of inositol tetrakisphosphates andemphasize the important role of 
cations such as Na +, K ÷, and Ca 2÷ in the receptor-mediated inositol response. Moreover, the results underscore the unique ability of 
carbachol (a cholinergic agonist) to stimulate significant accumulation of inositol tetrakisphosphate. 
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1. Introduction 
The regulation of phosphoinositide breakdown in brain 
is complex. Muscarinic c, holinergic agonists directly acti- 
vate phosphoinositidase C /31 through receptor-mediated 
stimulation of a heterotrimeric (GQ) protein [1,2]. There is 
ample evidence that elevation of intracellular Ca 2 + by any 
means will also stimulate phosphoinositide breakdown in 
permeabil ized neuroblastoma cells [3], brain slices [4-6] or 
synaptoneurosomes [7] incubated for 15-60 min with ago- 
nists in the presence of lithium after prior labeling with 
tritiated inositol. Under ~:hese conditions the major prod- 
ucts seen in the presence of agonists are labeled inositol 
monophosphates. Howew~r, it is now possible at early time 
Abbreviations: Ins 1,4,5-P 3,inositol 1,4,5 trisphosphate; Ins 1,3,4,5-P 4, 
inositol 1,3,4,5-tetrakisphosphate; IP 4, labeled inositol tetrakisphosphates; 
IP 3, labeled inositol trisphosphates; IPt_ 2, labeled inositol mono- and 
bisphosphates. 
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periods (2-5  min) to measure total inositol 1,4,5-tri- 
sphosphate (Ins 1,4,5-P 3) using radioligand binding assays 
as well as inositol 1,3,4,5-tetrakisphosphate (Ins 1,3,4,5- 
P4). Ins 1,4,5-P 3 is responsible for the release of Ca 2-- 
from intracellular compartments [8]. Ins 1,3,4,5-P 4 appears 
to modulate the entry of Ca 2÷ into cells and acts synergis- 
tically with Ins 1,4,5-P 3 in the control of Ca 2+ homeosta- 
sis [8-11]. 
Ins 1,4,5-P 3 can be metabolized by two different path- 
ways [12,13]. The first consists of a dephosphorylation to 
inositol 1,4-bisphosphate and inositol 4-monophosphate 
[12,13]. The second pathway involves the synthesis of Ins 
1,3,4,5-P 4 via an Ins 1,4,5-P 3 3-kinase catalyzed phospho- 
rylation of Ins 1,4,5-P 3 [9,14]. Dephosphorylation f Ins 
1,3,4,5-P 4 results in, primarily, formation of Ins 1,3,4-P 3
and further degradation to inositol 1-monophosphate 
[12,13]. The flux through these pathways is influenced by 
cytosolic concentrations of Ins 1,4,5-P 3, Ca 2+ and ATP 
[12]. At early time periods Ins 1,3,4,5-P 4 can accumulate at 
levels comparable to those of Ins 1,4,5-P 3 [15]. 
In a previous report [ 16] we showed that the formation 
20 M.E. Myles, J.N. Fain / Biochimica et Biophysica Acta 1310 (1996) 19-24 
of Ins 1,3,4,5-P 4 in rat brain cortical slices was stimulated 
only minimally by agents that elevate intracellular Ca 2÷ 
(i.e., ionomycin, NMDA, ouabain, veratridine). Although 
depolarization i duced by high K ÷ (18-40 mM) has been 
reported to increase phosphoinositide turnover in cerebral 
preparations [6,17,18], we were not able to detect a signifi- 
cant accumulation of Ins 1,3,4,5@ 4 following exposure of 
rat brain cortical slices to 30 mM K + for periods up to 5 
min [16]. Baudry et al. [19] found that elevated K ÷ did not 
inhibit the carbachol response in hippocampal s ices, while 
others [6,18] reported that elevated K ÷ (18 mM) actually 
enhanced carbachol stimulation of labeled inositol tris- 
and tetrakisphosphate ccumulation i cortical slices over 
a 5-min incubation. Similar effects of high K + (20-40 
mM) on the accumulation of total Ins 1,4,5-P 3 and Ins 
1,3,4,5-P 4 were also reported [15]. Our initial attempts to 
reproduce these findings were unsuccessful. Further efforts 
to determine the cause of the discrepancy revealed some 
insights into the possible mechanisms involved in the 
regulation of Ins 1,3,4,5-P 4 production and/or activity of 
the Ca 2+ calmodulin-sensitive 3-kinase that is responsible 
for phosphorylation of Ins 1,4,5-P 3 to Ins 1,3,4,5-P 4 
[9,12,20]. 
2. Materials and methods 
2.1. Preparation of  cerebral cortical slices 
Male Sprague-Dawley rats (125-175 g) were sacri- 
ficed by decapitation and the brains rapidly removed and 
placed on ice. Three or four rat brains were cleaned of 
meninges on ice, the cerebral cortices dissected free of 
white matter and cross-chopped into 350 × 350 /zm slices 
using a McIlwain tissue chopper (from the Mickle Lab, 
Engineering Co.). The chopped tissue was incubated in 
two 50-ml Erlenmeyer flasks each containing 15 ml of 
Krebs-Henseleit buffer containing 116 mM NaCI, 1.2 mM 
CaC12, 4.7 mM KC1, 1.2 mM MgSO 4, 1.2 mM KH2PO 4, 
25 mM NaHCO 3 and 11 mM glucose at pH 7.4 equili- 
brated with O2/CO 2 (95:5). The flasks were incubated in 
a 37°C orbital shaking water bath and shaken at 250 rpm 
for 15 min. The flasks were removed and the slices washed 
three times with Krebs-Henseleit buffer then incubated at 
37°C and shaken at 250 rpm for 2 h. 
2.2. Inositol 1,4,5-trisphosphate and inositol 1,3,4,5 tetra- 
kisphosphate measurements 
ice-cold 1 M TCA was added and the samples kept for 20 
min at 4°C. After centrifugation at 2800 × g for 15 min, 
200-/zl aliquots of the supernatant were removed and 
washed 4 times with 3 volumes of water-saturated dieth- 
ylether. A 100-/xl aliquot of the washed sample was 
removed and to this was added 25 /zl of 60 mM NaHCO 3 
and 25 /zl of 30 mM EDTA. Aliquots of the neutralized 
TCA extract were analyzed for inositol 1,4,5 trisphosphate 
and inositol 1,3,4,5 tetrakisphosphate using binding pro- 
teins made from bovine adrenal cortex and pig cerebellum, 
respectively, as described by Challiss and Nahorski [15]. 
After addition of the appropriate binding protein, samples 
were mixed and incubated at 4°C for 30 min with intermit- 
tent mixing. Separation of bound and free radioligand was 
achieved by centrifugation at 13,000 × g for 10 min [21]. 
After centrifugation, the supernatant was aspirated, and the 
membranes containing bound ligand were solubilized by 
adding 150/zl of 1% sodium dodecyl sulphate and heating 
in a boiling water bath for 45 min. After 3 h at room 
temperature, the contents of the microfuge tubes were 
transferred to scintillation vials, mixed with scintillant 
(Ecolume) and radioactivity determined by liquid scintilla- 
tion counting. Total mass in picomol was determined from 
the standard binding curves. When necessary, samples 
were diluted sufficiently to allow mass determination from 
the most sensitive part of the standard curve. The values 
are shown as the increments from the zero time values 
which averaged 0.7 picomol for inositol 1,3,4,5 tetrakis- 
phosphate and 18 picomol for inositol 1,4,5 trisphosphate. 
2.3. Measurement of  labeled inositol phosphates 
Slices were labeled by incubation for 2 h with 2 ~Ci /ml  
of [3H]inositol (0.1 mM). Aliquots (50 /zl) of gravity 
packed slices were added to 5-ml plastic tubes containing 
100 /zl of Krebs-Henseleit buffer and incubated for the 
indicated times with agonists at 37°C. lnositol phosphates 
were extracted with percholoric acid and the supernatants 
were neutralized with potassium hydroxide. The inositol 
phosphates were separated by chromatography using 
Dowex AG 1 × 8 resin [22]. 
2.4. Materials 
[3H]Inositol 1,4,5-trisphosphate, [3H]Inositol 1,3,4,5-te- 
trakisphosphate and myo-[3H]Inositol were all from 
Dupont-NEN, Boston, MA; USA. All other chemicals 
were of analytical grade. 
The slices, after a prior incubation at 37°C for 2 h, were 
washed three times with Krebs-Henseleit buffer containing 
4.7 mM K ÷. Increases in medium KC1 above 4.7 mM were 
offset by equivalent decreases in medium NaC1. 50 /zl of 
packed slices were incubated with ligands in a final vol- 
ume of 150 /xl of Krebs-Henseleit buffer for the indicated 
time periods in triplicate. At end of incubation, 150 /zl of 
3. Results 
Our studies were designed to examine the short-term 
accumulation of inositol phosphates especially inositol 
1,3,4,5-tetrakisphosphate (total Ins 1,3,4,5-P 4 or labeled 
IP4), in rat brain cortical slices. All studies were done in 
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Fig. 1. Dose-response for carbachol-stimulated accumulation of labeled 
inositol phosphates. Rat brain cortical slices were incubated for 120 min 
in buffer containing labeled inositol and 1.2 mM Ca 2÷, rinsed 4 times 
and incubated for 5 min in buffer containing 1.2 mM Ca z+ and either 4.7 
mM KC1 (circles), 10 mM KCI (triangles) or 30 mM KCI (diamonds) and 
the indicated concentrations o17 carbachol. Values represent means+ 
S.E.M. (triplicate determinations) of the increase over basal values (buffer 
containing 1.2 mM Ca 2+ and 4..7 mM K + ) at 5 min. The basal values 
were: IPland e, 1200 dpm; IP 3, 500 dpm; and 11>4, 185 dpm. 
the absence of Li + since :it does not increase the effects of 
agonists on the accumulation of tris- and tetrakisphos- 
phates during the first 5 min of incubation, and actually 
inhibits their accumulation during longer incubations 
[24,25]. The accumulation over 5 min of labeled IP 4 due to 
carbachol (Fig. 1) was enhanced in buffer containing 10 
mM K ÷ as compared to 4.7 mM K ÷ as previously shown 
[15]. For this reason we u:sed 10 mM K ÷ in all our studies. 
In the presence of 10 mM K ÷ the addition of carbachol 
resulted in an increase of labeled IP 4 accumulation (Fig. 1) 
which was linear between 0.5 and 5 min (data not shown). 
There was also a rapid accumulation of the isomers of IP 3. 
The accumulation of labeled IP 4 was at least 50% of the 
value for inositol trisphosphates. In fact, the increase in 
labeled inositol tris- and tetrakisphosphates at 5 min (Fig. 
1) accounted for one-third of the accumulation of total 
inositol phosphates in the presence of 1 mM carbachol. We 
did not separate the isomers of IP 3, but prior studies have 
indicated that inositol 1,4,5-trisphosphate predominates at 
early time points, while inositol 1,3,4-trisphosphate in- 
creases at later time points since it is derived from break- 
down of inositol 1,3,4,5-tetrakisphosphate by a 5-phos- 
phatase nzyme [13]. Elevation of medium K ÷ from 4.7 to 
10 mM doubled the accumulation of Ins 1,3,4,5-P 4 due to 
Table 1 
K + effects on inositol phosphate accumulation i rat brain cortical slices 
due to carbachol 
Additions K + in Inositol 1,3,4,5- Inositol 1,4,5- 
mM tetrakisphosphate trisphosphate 
Picomoles Picomoles 
None 4.7 < 0.1 1 ± 1 
Carbachol, 1mM 4.7 10+2 37+2 
None 10 < 0.1 1 + 1 
Carbachol, 1mM 10 22+2 39+3 
None 30 < 0. I 8 + 2 
Carbachol, 1mM 30 22+2 61+6 
Rat brain cortical slices were incubated for 120 min in buffer containing 
1.2 mM Ca 2+ and 4.7 mM K +, rinsed 4 times, then incubated for 2 min 
in buffer containing 1.2 mM Ca 2+ and either 4.7, 10 or 30 mM K ÷. The 
data are expressed in picomol per tube over the zero time values of 1 
picomol for inositol 1,3,4,5-tetrakisphosphate and20 picomol for inositol 
1,4,5-trisphosphate as the mean ± S.E.M. of 4 paired replications. 
1 mM carbachol without affecting the increase in Ins 
1,4,5-P 3 (Table 1). 
In contrast o the reports of others [6,15,17], we found 
differential effects of high K ÷ (30 mM) on carbachol- 
stimulated accumulation of labeled IP 4 versus accumula- 
tion of total Ins 1,3,4,5-P 4. Elevation of extracellular K ÷ to 
30 mM did not affect Ins 1,3,4,5-P 4 but did enhance 
carbachol stimulation of Ins 1,4,5-P 3 accumulation (Table 
1). Short-term (5 min) exposure of rat brain cortical slices 
to high K ÷ alone resulted in significant accumulation of 
labeled inositol mono-, bis- and trisphosphates (Fig. 1, 
Table 2). However, high K ÷ did not stimulate accumula- 
tion of labeled inositol tetrakisphosphates (Fig. 1, Table 2). 
Table 2 
Short-term effects of high K + on inositol phosphates in rat brain cortical 
slices. Rat brain cortical slices were incubated for 120 min in buffer 
containing 1.2 mM Ca 2+ and 4.7 mM K ÷, rinsed 4 times, and incubated 
for 5 min in buffer containing 10 or 30 mM K + 
K+ 30 mM K + 10mM+ 
Carbachol 1 mM 
A from basal 
Labeled inositol mono-, + 4770 + 150 b + 8460 + 935 b 
bis- and trisphosphates 
Labeled inositol tetrakis- + 20 ! 25 + 810 _+ 105 b 
phosphate(s) 
Total inositol - 0.5 + 0.6 + 24 -I-_ 3 b 
tetrakisphosphate 
Total inositol 1,4,5- + 13 ± 5 + 27 ± 2 b 
trisphosphate 
The values are the means + S.E.M. of the paired differences in 5 experi- 
ments for total inositol 1,4,5-trisphosphate and inositol 1,3,4,5 tetrakis- 
phosphate accumulation and for 4 experiments when tritiated inositol was 
present during the initial two-hour incubation. The data are expressed in
dpm or picomol per tube due to added agents over the basal values after 5 
min incubation in the presence of 10 mM K+: total inositol 1,3,4,5-tetra- 
kisphosphate, 1 picomol; inositol 1,4,5-trisphosphate, 29picomol; labeled 
inositol tetrakisphosphates, 180dpm; and labeled inositol tris-, bis- and 
monophosphates, 2000 dpm. Statistically significant differences from 
basal values are as follows: a p < 0.05 and b p < 0.01. 
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Table 3 
Effects of long-term high K + on carbachol stimulation of inositol 
1,3,4,5-tetrakisphosphate accumulation 
Buffer composition 5 min 2 min with 1 5 minutes 
Basal mM carbachol with 1 mM 
carbachol 
Inositol 1,3,4,5-tetrakisphosphate in picomol 
K + lOmM+ 
Na + 136 mM 2_+ 1 30_+4 34_+3 
K + 30 mM+Na + 2_+1 36_+5 33_+8 
l l6mM 
K + 30 mM+Na + 3_+1 41_+3 183_+25 
141 mM 
After an initial 15-rain incubation, slices were washed and added to flasks 
in Krebs-Henseleit buffer containing 4.7 mM K ÷ for a 60-min incuba- 
tion. Slices were washed and gased every 20 min for the first 60 min. 
After the third wash, 50 ~1 of slices were aliquoted into assay tubes 
containing the respective buffers without carbachol and incubated for an 
additional 60 min at 37°C prior to exposure to carbachol for either 2 or 5 
min. Data are expressed as picomol per 50-/~1 slice and represent the 
mean + S.E.M. of three experiments. 
High K + alone at 5 min stimulated total Ins 1,4,5-P 3
accumulation while having no effect on accumulation of 
Ins 1,3,4,5-P 4 (Table 2). At 5 min carbachol stimulated 
significant accumulation of labeled and total inositol phos- 
phates (Fig. 1, Table 2). 
It was reported [15] that high K + (20-40 mM) en- 
hanced the accumulation of Ins 1,4,5-P 3 and Ins 1,3,4,5-P 4 
at 5 min due to carbachol. In our studies, elevating K + 
from 10 to 30 mM while reducing Na + to maintain 
iso-osmolarity did not inhibit or potentiate carbachol stim- 
ulation at 2 min of Ins 1,3,4,5-P 4 accumulation (Table 1, 
Table 3). However, with long-term exposure, if we main- 
tained Na + at 141 mM while increasing the KCI content of 
the buffer from 5 to 30 mM we found a marked enhance- 
merit of carbachol-stimulated Ins 1,3,4,5-P 4 accumulation, 
especially at 5 rain (Table 3). These results indicate that 
there is no effect of increasing K ÷ from 10 to 30 mM on 
Ins 1,3,4,5-P 4 accumulation if Na ÷ is lowered by the same 
amount o maintain iso-osmolarity. 
The results in Table 3 suggested that it might be the 
16% increase in osmolarity due to elevation of K ÷ that 
accounted for the previously reported findings [6,15,17]. 
To examine this further, we exposed radiolabeled slices to 
carbachol in buffers that were either isotonic or hypertonic 
and measured the accumulation of inositol phosphates at 5 
min (Table 4). In our studies high K ÷ (30 mM) inhibited 
carbachol stimulated accumulation of labeled inositol te- 
trakisphosphates regardless of the osmolar status of the 
buffers used (Fig. 1, Table 4). Similar results were ob- 
served at 2 min (data not shown). These effects of high 
K ÷ on labeled (Tables 2 and 4) versus total inositol 
tetrakisphosphates (Tables 1 and 3) were consistently ob- 
served. This suggests that we may be examining different 
phospholipid pools [6,26]. Alternatively, owing to the com- 
plexity of slice preparations, we may be labeling a differ- 
ent cell type from that in which we observed the effects of 
high K ÷ on total Ins 1,3,4,5-P 4. 
The data in Fig. 1 demonstrate that in the presence of 
30 mM K ÷, and at all concentrations of carbachol in the 
range of 30 to 1000/zM, there were no effects on accumu- 
lation of inositol mono, bis- and trisphosphates. However, 
in the presence of 30 mM K ÷ there was no significant 
accumulation of labeled inositol tetrakisphosphates at any 
concentration of carbachol (Fig. 1). While one could argue 
that the effect of high K ÷ on labeled IP 4 involves en- 
hanced degradation, we are still left with an apparent lack 
of an effect on total Ins 1,3,4,5-P 4 (Tables 1 and 3). Thus 
in our studies a consistent pattern has emerged regarding 
the stimulation/regulation of inositol tetrakisphosphate ac-
Table 4 
Hypertonicity and K + effects on basal and carbachol stimulation of accumulation of labeled inositol phosphates 
Buffer changes Basal at 5 min + Carbachol at 5 min 
IPl 2 IP3 IP1-2 IP3 IP4 
50 mM sucrose 
30mMK + and l l6mMNa + 
30 mM K + and l l6mM Na + 
plus 50 mM sucrose 
30 mM K + and 141 mM Na + 
plus CI- 148 
Na + 161 mM and CI- 148 mM 
%ofK  + 10mM, Na + 136mM, CI 123mM 
99_+6 151+ 15 b 120+ 18 131+17 101+ 10 
257_+29 c 488_+89 b 133+ 12 1394- 13 a 33_+ 13a 
399+44 c 934+ 180 c 206+ 19 c 212+ 16 c 41 +9 b 
273_+30c 571+71c  115+10 131_+ 16 37_+9b 
54_+4 c 73_  16 b 109_+ 15 104-t-6 88+ 18 
Rat brain cortical slices were incubated for 2 h in the presence of labeled inositol, then the medium was removed prior to addition of the different buffers at 
room temperature. The medium was changed a total of four times and then the slices were incubated for 5 min at 37°C in either the absence or presence of 
1 mM carbachol. The data are the means + S.E.M. of 5 paired replications (except for inositol tetrakisphosphates which are data from three experiments) 
and expressed as % of the values in the presence of the standard buffer containing K ÷ 10 mM, Na + 136 mM and C1- 123 mM. The comparison buffers 
were all hyperosmotic by approximately 50milliosomol except for the buffer containing 30 mM K ÷ where the Na ÷ was reduced to 116 mM to maintain 
isotonicity. The accumulation of inositol mono- and bisphosphates was 2300 dpm in the absence and 7040 dpm in the presence of carbachol at 5 min in 
the basal buffer, while accumulation of labeled inositol trisphosphates was 260 dpm in the absence and 1365 dpm in the presence of carbachol. 
Accumulation of labeled inositol tetrakisphosphates wa 455 dpm in the presence of carbachol and undetectable in the absence of carbachol, ap < 0.05; 
b p < 0.025; c p < 0.01. 
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cumulation versus inositol mono, b is -or  trisphosphate 
accumulation (Fig. 1, Table 4) [16]. 
4. Discussion 
As noted above, a number of studies from Nahorski's 
laboratory reported that high K + (18-40 mM) enhances 
carbachol-stimulated accumulation of labeled inositol 
phosphates as well as totail Ins 1,4,5-P 3 and Ins 1,3,4,5-P 4 
in rat cerebral slices [5,6,15,17,18]. We were not able to 
see any potentiation by 30 mM K + of muscarinic 
receptor-stimulated inositol tetrakisphosphate accumula- 
tion (Fig. 1, Tables 1, 3 and 4). We observed a modest 
potentiation of the muscarinic response on total Ins 1, 4, 
5-P 3 (Table 1) and were only able to obtain high values for 
Ins 1,3,4,5-P 4 following long-term exposure of slices to 
high K + under conditions of high Na + (Table 3). The 
manner (iso-osmotic or hyper-osmotic) in which K + was 
elevated was not made clear in those studies. 
Although it is difficult to attribute the effect of high K ÷ 
on accumulation of labeled IP 4 to toxicity, it is a possibil- 
ity. In astrocytes, increased taurine release was observed 
when the external [K ÷] was raised iso-osmotically by 
substituting KC1 for NaC1, but not when external [K ÷ ] was 
raised hyper-osmotically by adding KCI directly to the 
medium [23]. We examined (data not shown) the effect of 
carbachol, K + and osmolar concentration on release of 
labeled taurine from rat brain cortical slices. As expected 
iso-osmotically elevated K + increased release of labeled 
taurine while increased osl~aolarity alone suppressed basal 
release. Carbachol also stimulated taurine release, which is 
in agreement with others ['.27] who reported that carbachol 
stimulated taurine release in rat sympathetic ganglia. Inter- 
estingly, the carbachol (cholinergic)-stimulated r lease of 
taurine appeared to have both a nicotinic and muscarinic 
receptor component [27]. 
Recent studies in cerebrocortical slices [28] and synap- 
toneurosomes [7,29,30] examined the role of Na + ions in 
the inositol response elicited by depolarizing stimuli 
(EAAs, KC1, sodium channel activators) or receptor ago- 
nists (carbachol, norepinephrine, tc.). The results indicate 
that Na+-influx and/or imracellular sodium may have an 
important regulatory role iin phosphoinositide metabolism 
[7,28-30]. Furthermore, the data suggest hat gradients of 
K +, Na + and Ca 2+ [7,28] are all involved in determining 
the final effect on phosphomositide turnover. It is proposed 
that the penultimate ffector in this activation process is 
the Na+/Ca 2+ exchanger which regulates intemal Ca 2+ 
and Ca 2+ activates phospholipase C [4,7,28-30]. The in- 
ability to detect significant accumulation of Ins 1,3,4,5-P 4 
with intracellular Ca2+-elevating agents [5,6,16] suggests 
that carbachol stimulates IrLs 1,3,4,5-P 4 accumulation by an 
independent mechanism(s) or the metabolism of different 
pools of membrane phosphoinositides [6,16,26,29]. 
Elevating K + either iso-osmotically or hyper-osmoti- 
cally changes the Na+/K  + ratio. Our data suggests that it 
is the change in the relative concentration of these two 
ions that is responsible for the effects of high K + on 
labeled IP 4 accumulation. Thus elevating K + with or 
without a change in Na + results in inhibition of labeled IP 4 
accumulation due to carbachol (Table 4). The ability of 
hyper-osmotically elevated NaC1 (Table 4) to lower basal 
accumulation of inositol mono-, bis- and trisphosphates 
would seem to support his argument. Although our Na + 
or K + reductions or additions were modest, such changes 
have been reported to have major effects on release of 
radiolabeled taurine [23] and high K + (30 mM) or EAA 
stimulated accumulation of inositol phosphates over 20-45 
min [29,30]. 
The marked specificity of the cerebellar binding protein 
for Ins 1,3,4,5-P 4 as compared to Ins 1,4,5-P 3 (respective 
ICs0 values of 3_+1 nM and 19_+6.7 /zM) has been 
convincingly demonstrated [31,32]. These and other re- 
ports [33,34] demonstrated that optimal binding of radiola- 
beled Ins 1,3,4,5-P 4 occurred using an assay buffer at pH 
5.0 containing 25 mM KHzPO 4. At pH 5, Ins 1,3,4,5-P 4 
binding was maximal, whereas radiolabeled Ins 1,4,5-P 3
binding (to the Ins 1,4,5-P 3binding site) was undetectably 
low [33,34]. Conversely, radiolabeled Ins 1,4,5-P 3 binding 
to its binding site was maximal at pH 8.0, while Ins 
1,3,4,5-P 4 binding (at this pH) is very low [33,34]. These 
findings make it highly unlikely that the differential effect 
of high K + on total versus labeled IP 4 can be attributed to 
cross-reactivity of Ins 1,4,5@ 3 in the Ins 1,3,4,5-P 4 mass 
assay. 
Although residual 3-phosphatase activity could possibly 
degrade Ins 1,3,4,5-P 4 to Ins 1,4,5-P 3, the acidic assay 
conditions would prevent Ins 1,4,5-P 3 binding to the Ins 
1,4,5-P 3 binding sites present [33]. Likewise, the working 
conditions used for the binding studies (4°C, addition of 2 
mM EDTA in the absence of Mg 2+) were designed to 
reduce/inhibit any residual MgZ+-dependent 5-phos- 
phatase activity which could degrade the label [31,32,35]. 
In a rat cerebral cortical preparation no significant 
metabolism occurred uring the 30-min assay, with > 98% 
of radioactivity recovered as Ins 1,3,4,5-P 4 after acid pre- 
cipitation of the binding protein and HPLC analysis of the 
neutralized samples [31]. Thus significant interference by 
Ins 1,4,5-P 3 (or Ins 1,3,4-P 3) in the Ins 1,3,4,5-P 4 mass 
assay appears unlikely. 
Our working hypothesis has been that the formation of 
Ins 1,3,4,5-P 4 is not simply secondary to elevation of Ca 2+ 
and Ins 1,4,5-P a but is uniquely regulated. The restricted 
subcellular localization of the enzyme that converts Ins 
1,4,5-P 3 to Ins 1,3,4,5-P 4 would seem to support this 
argument. The kinase (Ins 1,4,5-P 3 3-kinase) is present at 
highest concentration i the dendritic spines of neuronal 
cells [36-38]. The Ins 1,4,5-P 3kinase is primarily found in 
the dendritic spines of pyramidal neurons associated with 
the spine apparatus and plasmalemma with the post- 
synaptic densities howing the highest amount of the en- 
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zyme [37]. It was suggested that the functional role of the 
3-kinase is related to the postsynaptic processing of signals 
in dendritic spines of some cerebral neurons [37]. Further- 
more, the data suggest that the dendritic spines may be the 
unique sites in the central nervous system where Ins 
1,3,4,5-P 4 may function in the control of local Ca 2÷ 
circuits and in the development of synaptic plasticity [37]. 
As alluded to above, muscarinic and a-adrenergic ago- 
nists were shown to stimulate phosphoinositide breakdown 
in radiolabeled synaptoneurosomes [7,29,30]. Synaptoneu- 
rosomes consist of synaptosomes (resealed presynaptic 
vesicles) with attached neurosomes (resealed postsynaptic 
membranes) [39]. Guinea pig synaptoneurosomal prepara- 
tions have been used extensively for investigation of the 
formation of cyclic-AMP [39]. The synaptoneurosome 
preparation appears to provide a 'cleaner' alternative to 
brain slices for studying phosphoinositide metabolism in 
the brain. Thus, fruitful future investigations into the phe- 
nomenon presented in this report will most likely require 
use of a synaptoneurosomal preparation. 
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